Actual Medicinal Product (AMP) Trajenta 5mg tablets (CST Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Trajenta 5mg tablets (Boehringer Ingelheim Ltd).

Generic
Linagliptin
Formulation
Linagliptin 5mg tablets
  • Linagliptin
    • Linagliptin 5mg tablets

      • Trajenta 5mg tablets (CST Pharma Ltd)



Related Formulations (1)

compatible logo Linagliptin 5mg tablets